169 related articles for article (PubMed ID: 31373689)
1. The association of pharmacy fill synchronization with breast cancer endocrine therapy adherence.
Neuner JM; Fergestrom NM; Laud PW; Nattinger AB; Beyer KMM; Flynn KE; Pezzin LE
Cancer; 2019 Nov; 125(22):3960-3965. PubMed ID: 31373689
[TBL] [Abstract][Full Text] [Related]
2. Factors Influencing Prescription Drug Synchronization: The Complex Role of Number of Medications.
Neuner JM; Fergestrom N; Laud PW; Pezzin L
J Manag Care Spec Pharm; 2019 Jun; 25(6):714-718. PubMed ID: 31134859
[TBL] [Abstract][Full Text] [Related]
3. Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer.
Neuner JM; Fergestrom N; Pezzin LE; Laud PW; Ruddy KJ; Winn AN
Breast Cancer Res Treat; 2023 Jan; 197(1):223-233. PubMed ID: 36357711
[TBL] [Abstract][Full Text] [Related]
4. Effects of Previous Medication Regimen Factors and Bipolar and Psychotic Disorders on Breast Cancer Endocrine Therapy Adherence.
Haskins CB; Neuner JM; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
Clin Breast Cancer; 2020 Jun; 20(3):e261-e280. PubMed ID: 32139273
[TBL] [Abstract][Full Text] [Related]
5. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
6. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
Lundgren C; Lindman H; Rolander B; Ekholm M
Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
[TBL] [Abstract][Full Text] [Related]
7. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system.
Kroenke CH; Hershman DL; Gomez SL; Adams SR; Eldridge EH; Kwan ML; Ergas IJ; Kubo A; Kushi LH
Breast Cancer Res Treat; 2018 Aug; 170(3):623-631. PubMed ID: 29671113
[TBL] [Abstract][Full Text] [Related]
8. Impact of patient race and geographical factors on initiation and adherence to adjuvant endocrine therapy in medicare breast cancer survivors.
Camacho FT; Tan X; Alcalá HE; Shah S; Anderson RT; Balkrishnan R
Medicine (Baltimore); 2017 Jun; 96(24):e7147. PubMed ID: 28614244
[TBL] [Abstract][Full Text] [Related]
9. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
[TBL] [Abstract][Full Text] [Related]
10. Association of Endocrine Therapy Initiation Timeliness With Adherence and Continuation in Low-Income Women With Breast Cancer.
Sood N; Liu Y; Lian M; Greever-Rice T; Lucht J; Schmaltz C; Colditz GA
JAMA Netw Open; 2022 Aug; 5(8):e2225345. PubMed ID: 35921108
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with endocrine therapy adherence among post-menopausal women treated for early-stage breast cancer in Ontario, Canada.
Blanchette PS; Lam M; Richard L; Allen B; Shariff SZ; Vandenberg T; Pritchard KI; Chan KKW; Louie AV; Desautels D; Raphael J; Earle CC
Breast Cancer Res Treat; 2020 Jan; 179(1):217-227. PubMed ID: 31571072
[TBL] [Abstract][Full Text] [Related]
12. Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature.
Sattler EL; Lee JS; Perri M
Drugs Aging; 2013 Jun; 30(6):383-99. PubMed ID: 23553512
[TBL] [Abstract][Full Text] [Related]
13. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer.
Neugut AI; Subar M; Wilde ET; Stratton S; Brouse CH; Hillyer GC; Grann VR; Hershman DL
J Clin Oncol; 2011 Jun; 29(18):2534-42. PubMed ID: 21606426
[TBL] [Abstract][Full Text] [Related]
14. Impact of preexisting mental illness on breast cancer endocrine therapy adherence.
Haskins CB; McDowell BD; Carnahan RM; Fiedorowicz JG; Wallace RB; Smith BJ; Chrischilles EA
Breast Cancer Res Treat; 2019 Feb; 174(1):197-208. PubMed ID: 30465157
[TBL] [Abstract][Full Text] [Related]
15. Predicting adjuvant endocrine therapy initiation and adherence among older women with early-stage breast cancer.
Meneveau MO; Keim-Malpass J; Camacho TF; Anderson RT; Showalter SL
Breast Cancer Res Treat; 2020 Dec; 184(3):805-816. PubMed ID: 32920742
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant hormonal therapy use among insured, low-income women with breast cancer.
Kimmick G; Anderson R; Camacho F; Bhosle M; Hwang W; Balkrishnan R
J Clin Oncol; 2009 Jul; 27(21):3445-51. PubMed ID: 19451445
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Out-of-Pocket Costs and Adherence to Adjuvant Endocrine Therapy Among Newly Diagnosed Breast Cancer Patients.
Farias AJ; Hansen RN; Zeliadt SB; Ornelas IJ; Li CI; Thompson B
Am J Clin Oncol; 2018 Jul; 41(7):708-715. PubMed ID: 27893470
[TBL] [Abstract][Full Text] [Related]
18. Financial impact of patients enrolled in a medication adherence program at an independent community pharmacy.
Clifton CL; Branham AR; Hayes HH; Moose JS; Rhodes LA; Marciniak MW
J Am Pharm Assoc (2003); 2018; 58(4S):S109-S113. PubMed ID: 30006182
[TBL] [Abstract][Full Text] [Related]
19. Endocrine adherence in male versus female breast cancer: a seer-medicare review.
Ali A; Xie Z; Stanko L; De Leo E; Hong YR; Bian J; Daily KC
Breast Cancer Res Treat; 2022 Apr; 192(3):491-499. PubMed ID: 35142938
[TBL] [Abstract][Full Text] [Related]
20. The impact of a retail prescription synchronization program on medication adherence.
Girdish C; Shrank W; Freytag S; Chen D; Gebhard D; Bunton A; Choudhry N; Polinski J
J Am Pharm Assoc (2003); 2017; 57(5):579-584.e1. PubMed ID: 28764890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]